Strides Pharma Science Limited

Equities

STAR

INE939A01011

Pharmaceuticals

Market Closed - NSE India S.E. 07:40:47 2024-04-16 am EDT 5-day change 1st Jan Change
839.5 INR +1.02% Intraday chart for Strides Pharma Science Limited +0.15% +29.30%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Strides Pharma Science Gets US FDA Nod for Fluoxetine Tabs MT
Transcript : Strides Pharma Science Limited, Q3 2024 Earnings Call, Jan 30, 2024
Strides Pharma Science Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Strides Pharma Science Arm Gets US FDA Nod for Pregabalin Capsules MT
Strides Pharma Science's Swiss Unit to Sell Entire Stake in Eris Pharma MT
Strides Pharma Science Arm Acquires Additional 25% Stake in Neviton Softech MT
Strides Pharma Science Acquires Minority Stake in Two Renewable Energy Companies MT
Strides Pharma Science Subsidiary Secures Credit Facility Worth INR319 Million MT
India's Nifty set to open at new record highs for second session in a row RE
Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules CI
Strides Pharma Unit Gets US FDA Approval for Generic Bowel Prep Kit Solution MT
Strides Pharma Global Pte. Limited Receives USFDA Approval for Generic Suprep®? Bowel Prep Kit CI
Strides Pharma Science Arm Gets US FDA's Nod for Generic Seizure Treatment MT
Strides Pharma Science Appoints COO MT
Transcript : Strides Pharma Science Limited, Q2 2024 Earnings Call, Oct 30, 2023
Strides Pharma Science Limited Announces Change in Management CI
Strides Pharma Science Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Strides Pharma Science to Sell Singapore Manufacturing Site for $15 Million MT
Strides Pharma Arm Gets US FDA Nod for HIV Treatment Drug MT
Strides Pharma Unit Gets US FDA Approval for Generic HIV Drugs MT
Strides Pharma Global Pte. Limited Receives USFDA Approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate Tablets CI
INDIA STOCKS-Indian shares seen opening lower amid sustained foreign selling RE
Transcript : Strides Pharma Science Limited - Special Call
India's Strides Pharma to spin off contract development unit RE
Strides Pharma Science Arm Gets US FDA Nod for Icosapent Ethyl Capsules MT
Chart Strides Pharma Science Limited
More charts
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche and pharmaceutical products. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
831 INR
Average target price
830.5 INR
Spread / Average Target
-0.06%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. STAR Stock
  4. News Strides Pharma Science Limited
  5. Strides Pharma Science : , TLC Get Regulatory Nod to Import Fungal Infection Drug in India